246 related articles for article (PubMed ID: 33510271)
21. [Efficacy of combined 5-nitroimidazole and probiotic therapy of bacterial vaginosis: randomized open trial].
Kovachev S; Vatcheva-Dobrevski R
Akush Ginekol (Sofiia); 2013; 52(3):19-26. PubMed ID: 24283058
[TBL] [Abstract][Full Text] [Related]
22.
Ansari A; Son D; Hur YM; Park S; You YA; Kim SM; Lee G; Kang S; Chung Y; Lim S; Kim YJ
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111086
[TBL] [Abstract][Full Text] [Related]
23. Effect of vaginal probiotics containing Lactobacillus casei rhamnosus (Lcr regenerans) on vaginal dysbiotic microbiota and pregnancy outcome, prospective, randomized study.
Petricevic L; Rosicky I; Kiss H; Janjic N; Kaufmann U; Holzer I; Farr A
Sci Rep; 2023 May; 13(1):7129. PubMed ID: 37130874
[TBL] [Abstract][Full Text] [Related]
24.
Rapisarda AMC; Pino A; Grimaldi RL; Caggia C; Randazzo CL; Cianci A
Front Surg; 2022; 9():1075612. PubMed ID: 36700035
[TBL] [Abstract][Full Text] [Related]
25. Lacticaseibacillus rhamnosus GR-1, a.k.a. Lactobacillus rhamnosus GR-1: Past and Future Perspectives.
Petrova MI; Reid G; Ter Haar JA
Trends Microbiol; 2021 Aug; 29(8):747-761. PubMed ID: 33865678
[TBL] [Abstract][Full Text] [Related]
26. Vaginal impact of the oral administration of total freeze-dried culture of LCR 35 in healthy women.
Bohbot JM; Cardot JM
Infect Dis Obstet Gynecol; 2012; 2012():503648. PubMed ID: 22701297
[TBL] [Abstract][Full Text] [Related]
27.
Stivala A; Carota G; Fuochi V; Furneri PM
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33450875
[No Abstract] [Full Text] [Related]
28. Lacticaseibacillus rhamnosus Lcr35 Stimulates Epithelial Vaginal Defenses upon Gardnerella vaginalis Infection.
Miquel S; Verlaguet J; Garcin S; Bertran T; Evrard B; Forestier C; Vareille-Delarbre M
Infect Immun; 2022 Sep; 90(9):e0030922. PubMed ID: 36000874
[TBL] [Abstract][Full Text] [Related]
29. Lacticaseibacillus rhamnosus TR08 alleviated intestinal injury and modulated microbiota dysbiosis in septic mice.
Yin J; Sun W; Yu X; Xiao X; Li B; Tong Z; Ke L; Mao W; Li W
BMC Microbiol; 2021 Sep; 21(1):249. PubMed ID: 34536996
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.
Husain S; Allotey J; Drymoussi Z; Wilks M; Fernandez-Felix BM; Whiley A; Dodds J; Thangaratinam S; McCourt C; Prosdocimi EM; Wade WG; de Tejada BM; Zamora J; Khan K; Millar M
BJOG; 2020 Jan; 127(2):275-284. PubMed ID: 30932317
[TBL] [Abstract][Full Text] [Related]
31. [GynOphilus--a winning relay].
Kovachev S
Akush Ginekol (Sofiia); 2012; 51 Suppl 1():41-4. PubMed ID: 23236678
[TBL] [Abstract][Full Text] [Related]
32. The Need to Focus on Therapy Instead of Associations.
Reid G
Front Cell Infect Microbiol; 2019; 9():327. PubMed ID: 31572693
[TBL] [Abstract][Full Text] [Related]
33. Exploring of probiotic potential vaginal lactobacillus isolates from healthy women against Gardnerella vaginalis and Caenorhabditis elegans model testing.
Li Y; Jiang Y; Lessing DJ; Chu W
J Appl Microbiol; 2022 Sep; 133(3):1392-1401. PubMed ID: 35633296
[TBL] [Abstract][Full Text] [Related]
34. Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice.
Jang SE; Jeong JJ; Choi SY; Kim H; Han MJ; Kim DH
Nutrients; 2017 May; 9(6):. PubMed ID: 28545241
[TBL] [Abstract][Full Text] [Related]
35. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the probiotic properties of
Chung Y; Kang SB; Son D; Lee JY; Chung MJ; Lim S
Front Microbiol; 2023; 14():1308293. PubMed ID: 38098667
[TBL] [Abstract][Full Text] [Related]
37. Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study.
Mezzasalma V; Manfrini E; Ferri E; Boccarusso M; Di Gennaro P; Schiano I; Michelotti A; Labra M
Arch Gynecol Obstet; 2017 Jan; 295(1):163-172. PubMed ID: 27826653
[TBL] [Abstract][Full Text] [Related]
38. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis.
Marcone V; Rocca G; Lichtner M; Calzolari E
Int J Gynaecol Obstet; 2010 Sep; 110(3):223-6. PubMed ID: 20573348
[TBL] [Abstract][Full Text] [Related]
39. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.
Martinez RC; Franceschini SA; Patta MC; Quintana SM; Gomes BC; De Martinis EC; Reid G
Can J Microbiol; 2009 Feb; 55(2):133-8. PubMed ID: 19295645
[TBL] [Abstract][Full Text] [Related]
40. Detection of vaginal lactobacilli as probiotic candidates.
Pino A; Bartolo E; Caggia C; Cianci A; Randazzo CL
Sci Rep; 2019 Mar; 9(1):3355. PubMed ID: 30833631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
